Compare Pfizer Inc (PFE) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Rush Street Interactive Inc — how do they compare? Pfizer Inc trades at $28.06 (market cap $158.56B), while Rush Street Interactive Inc trades at $19.75 (market cap $2.35B). The key difference: Pfizer Inc is far larger — about 67.5× Rush Street Interactive Inc's market cap, and Pfizer Inc pays a 6.18% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Rush Street Interactive Inc for 13 Days on average.
| PFE | RSI | |
|---|---|---|
Market Cap | $158.56B | $2.35B |
Volume | 44,138,282 | 2,219,374 |
Sector | Health | Consumer Cyclical |
52-Week High | $29.02 | $34.52 |
52-Week Low | $23.67 | $15.89 |
Typical Hold Time | 158 Days | 13 Days |
Enterprise Value | $210.06B | $2.01B |
Dividend Yield | 6.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
RSI trades at $20.24, down 1.56% with bearish technical signals but strong analyst support. The company shows revenue growth from $1.13B in 2025 to $1.4B projected for 2026, though net income margin compressed from 2.93% to 2.33%. Recent Q2 2026 earnings beat expectations with $0.15 EPS versus $0.1499 expected. Technical indicators show mixed signals with moving averages bearish but oscillators neutral, while institutional activity includes BlackRock's $448M investment in August 2026.
The stock presents a compelling valuation gap with consensus price target of $34.88 representing 72% upside, supported by 77% buy ratings from analysts. Key risks include competitive pressures in online gaming and margin compression despite revenue growth. The company's participation in major industry conferences and strong institutional backing provides fundamental support for long-term growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
